Metabolic-associated fatty liver disease (MAFLD) is the most prevalent chronic liver disease
worldwide, affecting 25% of people globally and up to 80% of people with obesity. MAFLD is …

Conclusions: The panel found consistent and compelling evidence that regular physical
activity plays an important role in preventing NAFLD and improving intermediate clinical …

Exercise is an effective non-pharmacological strategy for ameliorating nonalcoholic fatty
liver disease (NAFLD), but the underlying mechanism needs further investigation. Cysteine …

Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the
American College of Sports Medicine Page 1 Physical Activity and Nonalcoholic Fatty Liver …

Background and aims Non-alcoholic fatty liver disease (NAFLD) has emerged as a major
chronic liver disease. We explored simple and effective ways to improve NAFLD and …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of
the world's adult population. While it is associated with obesity and metabolic syndrome …

Abstract Background and Aims Exercise training is recommended for all patients with
metabolic dysfunction‐associated steatotic liver disease and may reverse liver fibrosis …

ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …

Exercise remains a key component of nonalcoholic fatty liver disease (NAFLD) treatment.
The mechanisms that underpin improvements in NAFLD remain the focus of much …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disorders ranging
from simple steatosis to non-alcoholic steatohepatitis (NASH). Hepatic steatosis may result …